Search Results

Business

Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a member of the Management Team

Bioretec Ltd, a pioneer in biodegradable orthopedic implants, has, as of June 17, 2024, appointed Frank Sarcone as Vice President of Sales for the United States and a member of Bioretec’s Management Team.

June 18, 2024

·

3 min read

Business

Inside information: Alan Donze has been appointed as Bioretec’s new CEO

Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec as of , 20 May 2024.

May 20, 2024

·

5 min read

Inside Information: Update for Bioretec’s RemeOs™ Trauma Screw European Marketing Authorization

Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, announces that according to the information received from the Notified Body, its European CE mark market authorization application for the RemeOs™ trauma screw has returned from the expert panel evaluation.

June 27, 2024

·

2 min read

Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses

This announcement summarizes Bioretec Ltd’s business review for January-March 2024.

May 16, 2024

·

6 min read

Notice of Annual General Meeting (AGM) of Bioretec Ltd

The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m.

April 5, 2024

·

14 min read

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures

Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of cases have been performed around the U.S. utilizing the RemeOs™ technology.

June 19, 2024

·

2 min read

Business

Bioretec Ltd’s Annual Report and Financial Statements 2023 published

Bioretec Ltd has published its 2023 Annual Report, Financial Statements and Report by the Board of Directors.

March 15, 2024

·

2 min read

Business

Bioretec Ltd’s financial statements bulletin 2023: Another successful year in the growth trajectory

This announcement is a summary of Bioretec Ltd’s financial statements bulletin for January-December 2023.

February 16, 2024

·

9 min read

Inside information: Bioretec’s RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office

Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has been allowed a patent by the U.S. patent office for its RemeOs™ magnesium alloy composition.

March 21, 2024

·

2 min read

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage

Bioretec Ltd. has today been granted Breakthrough Device Designation for its RemeOs™ Spinal Interbody Cage implant from the US Food and Drug Administration, confirming that the product represents a breakthrough technology in spinal surgery.

March 14, 2024

·

3 min read